A detailed history of Fcg Investment CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Fcg Investment CO holds 11,651 shares of ABBV stock, worth $2.05 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
11,651
Previous 7,436 56.68%
Holding current value
$2.05 Million
Previous $1.28 Billion 80.4%
% of portfolio
1.51%
Previous 0.97%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $690,585 - $840,175
4,215 Added 56.68%
11,651 $2.3 Billion
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $50,461 - $58,927
-326 Reduced 4.2%
7,436 $1.28 Billion
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $1.24 Million - $1.41 Million
7,762 New
7,762 $1.41 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fcg Investment CO Portfolio

Follow Fcg Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcg Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Fcg Investment CO with notifications on news.